SMAD4 and invasive carcinoma: SMAD4 mutations are rarely observed in IPMNs while enriched in invasive carcinomas, thereby suggesting that they are acquired during late stages of tumorigenesis; the hypothesis that alterations involving SMAD4 may drive malignant transformation and invasion in a subset of lesions is supported by a recent work by Noë et al. [66,67,72,88].